The Prevention of Heart Attacks and Strokes: A Disease-Inflammatory Approach

The Prevention of Heart Attacks and Strokes: A Disease-Inflammatory Approach

Speaker Name/Credentials

Amy L. Doneen, DNP, ARNP
Medical Director – Heart Attack & Stroke Prevention Center, Co-Founder – Bale/Doneen Method, Adjunct Professor – Texas Tech University Health Sciences
Spokane, WA

Estimated time of Talk

30 minutes

Description

This webinar will cover imaging modalities and biomarkers for the identification of cardiovascular disease.

Learning Objectives

  • Understand the techniques to assess for the presence of subclinical atherosclerosis.
  • Understand event reality and the general concept of atherosclerosis and vascular inflammation.
  • Understand the various root causes associated with the development of vascular inflammation and atherosclerosis.

Conflicts of Interest

Consultant – Cleveland HeartLab

Consultant – MyGenetics

New Concepts in the Diagnosis and Treatment of Hypertension: The Role of Endothelial Function, Vascular Biology, Nitric Oxide, ADMA and SDMA

New Concepts in the Diagnosis and Treatment of Hypertension

Speaker Name/Credentials

Mark Houston, MD, MS, MSc, ABAARM, FACP, FAHA, FASH, FACN, FAARM
Director, Hypertension Institute and Vascular Biology
Saint Thomas West Hospital
Nashville, TN

For more information about Dr. Houston, please visit:
http://hypertensioninstitute.com/doctor/dr-mark-houston/

Estimated time of Talk

45 minutes

Learning Objectives

  • Understand the pathogenesis of hypertension and Endothelial Dysfunction
  • Review the role of vascular biology, three finite vascular responses (inflammation, oxidative stress and vascular immune function), plasma renin activity (PRA) and aldosterone to select optimal integrative anti-hypertensive therapy to reduce BP and decrease CVD.
  • Review the role of Nitric Oxide, ADMA and SDMA in hypertension and CVD
  • Review diagnostic testing for hypertension: 24 hour ambulatory BP (ABM), endothelial function and arterial compliance testing.
  • Be able to prioritize and personalize the most important nutritional, nutraceutical supplements and life style treatments for hypertension

Conflicts of Interest

Dr. Houston is an independent contractor/consultant for Biotics Research, Spectracell, Designs for Health, Thorne, Vibrant America Labs, Cleveland HeartLab and AC Grace and he is on the review panel/board for Designs for Health, Thorne, Boston Heart Lab, Itamar and receives grants from private industry from Biotics, Thorne and Neogenis.

Vascular Inflammation and Nitric Oxide: Bridging Diagnostics to Personalized Therapies

 Nathan Bryan Vascular Inflammation and NO

Speaker Name / Credentials

Nathan S. Bryan, Ph.D.
Baylor College of Medicine, Houston, TX

Estimated time of Talk

45 minutes

Description

This webinar will cover the importance of nitric oxide in vascular inflammation and how it relates to specific diagnostics.

Learning Objectives

  • Explain the regulation of vascular and systemic NO production
  • Describe the link between inflammation and NO
  • Reveal novel strategies to replete NO production and suppress inflammation

Disclosures

Co-Founder and Chief Science Officer, Neogenis Labs, Inc.

ADMA/SDMA to Assess Endothelial Health

Mark Houston ADMA/SDMA

Speaker Name / Credentials

Mark Houston, MD, MS, MSc, ABAARM, FACP, FAHA, FASH, FACN, FAARM
Hypertension Institute of Nashville, Nashville, TN

Estimated time of Talk

30 minutes

Description

This webinar will cover the role of ADMA/SDMA in the assessment of endothelial health.

Learning Objectives

  • Understand the role of ADMA and SDMA in vascular disease and renal dysfunction.
  • Understand the role of vascular biology in atherosclerosis vascular disease, CHD and CVD.
  • Understand the role of endothelial dysfunction and nitric oxide in CVD.
  • Understand how inflammation, oxidative stress and vascular immune dysfunction promote CVD and CHD.

Disclosures

Independent contractor/consultant/speaker/researcher for Itamar, Biotics Research, Spectracell, BHL, CHL, CardioDX, Neogenis, Designs for Health, Thorne and AC Grace.

Assessing Cardiovascular Risk Through the Use of Inflammation Testing

MarcPenn-NonCME-Thumb
Speaker Name / Credentials

Marc Penn, MD, PhD, FACC
Co-Founder and Chief Medical Officer
Cleveland HeartLab, Inc.

Estimated time of Talk

40 minutes

Description

This webcast will overview inflammatory biomarker testing for cardiovascular risk assessment

Learning Objectives

  • Describe the management of heart disease risk
  • Understand the national behind inflammation testing
  • Discuss multiple inflammatory biomarkers and how they can allow for greater risk stratification

Target Audience

Primary Care Physicians, Internal Medicine, and Specialists

Assessment of Heart Failure: Early Identification and Across the Spectrum

JamesJanuzzi-CME-Thumb

Speaker Name/Credentials

James L. Januzzi, Jr. MD, FACC, FESC
Hutter Family Professor of Medicine, Harvard Medical School; DeSanctis Endowed Clinical Scholar, Massachusetts General Hospital Cardiometabolic Trial Group, Harvard Clinical Research Institute

Estimated Time of Talk

40 minutes

Description

This webcast will cover identification, assessment, biomarkers and treatment considerations for heart failure.

Learning Objectives

  • Identify biomarkers that may help to recognize and manage patients with heart failure
  • Understand how to optimally use natriuretic peptides in the acute diagnosis of heart failure

Target Audience                                             

Primary Care Physicians, Internal Medicine and, Specialists

Conflicts of Interest

Grants: Roche Diagnostics, Critical Diagnostics, Singulex, Thermo Fisher
Consulting and/or CEC participation: Roche Diagnostics, Critical Diagnostics, Amgen, Zensun, Novartis, Radiometer, Boeringer-Ingelheim

 

Imaging & Inflammation: Applying the Evidence to Clinical Practice

AmyDoneen-CME-Thumb

Speaker Name/Credentials

Amy L. Doneen, DNP, ARNP
Adjunct Professor at TTUHS School of Nursing
Director of the Heart Health & Stroke Prevention Center
Spokane, Washington

Estimated time of Talk

40 minutes

Description

This webcast will overview the role of inflammation in cardiovascular disease and the use of different biomarkers and imaging modalities for risk assessment.

Learning Objectives

  • Discuss the magnitude of vascular disease
  • Describe Atherosclerosis as a silent threat and Inflammation as the catalyst for an event
  • Describe the use of inflammatory biomarkers for clinical application
  • Share a case application of using biomarkers and imaging to best assess risk

Target Audience

Primary Care Physicians, Internal Medicine and, Specialists 

Disclosures

Co-founder of the Bale/Doneen Method for the prevention of Heart Attack, Stroke & Diabetes.
Consultant and speaker for Cleveland HeartLab, Inc.
Adjunct Professor at Texas Tech University Health Sciences School of Nursing

 

Assessing Risk of Heart Failure: A Closer Look at the Clinical Utility of Galectin-3

PeterMcCullough-CME-Thumb

Speaker Name/Credentials:

Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF
Baylor University Medical Center, Dallas, Texas

Estimated time of Talk

30 minutes

Description

This webcast will overview the heart failure epidemic and biomarker technology currently available to improve patient management and outcomes.

Learning Objectives

  • Review the classical assessment for the identification of heart failure
  • Understand the pathophysiology that drives the initiation and development of heart failure
  • Distinguish Galectin-3 and NT-proBNP as complementary biomarkers of heart failure
  • Review the role of Galetin-3 in the identification and management of heart failure

Target Audience

Primary Care Physicians, Internal Medicine and, Specialists

Conflicts of Interest

Dr. McCullough is a consultant for BG Medicine, Inc.